SAB Biotherapeutics, Inc.
SABS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$34 | -$42 | -$19 | -$17 |
| Dep. & Amort. | $5 | $4 | $3 | $2 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $3 | $2 | $3 | $0 |
| Change in WC | -$2 | $2 | -$0 | $12 |
| Other Non-Cash | -$6 | $9 | -$10 | $6 |
| Operating Cash Flow | -$34 | -$25 | -$23 | $2 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$2 | -$11 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$37 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $26 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$12 | -$0 | -$2 | -$11 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1 | -$0 | -$1 | $2 |
| Stock Issued | $0 | $0 | $8 | $0 |
| Stock Repurch. | $0 | $0 | -$6 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$0 | $67 | $0 | $34 |
| Financing Cash Flow | -$1 | $67 | $1 | $36 |
| Forex Effect | -$0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$48 | $42 | -$24 | $27 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $57 | $15 | $40 | $13 |
| End Cash | $9 | $57 | $15 | $40 |
| Free Cash Flow | -$35 | -$25 | -$26 | -$9 |